Annual report pursuant to Section 13 and 15(d)

Liquidity (Narrative) (Details)

v3.3.1.900
Liquidity (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
May. 15, 2015
Liquidity [Line Items]                        
Lymphoseek sales revenue $ 3,503,000 $ 2,953,000 $ 1,964,000 $ 1,835,000 $ 1,460,000 $ 1,101,000 $ 1,046,000 $ 627,000 $ 10,254,352 $ 4,233,953 $ 614,423  
Capital Royalty Partners II LP [Member]                        
Liquidity [Line Items]                        
Liquidity minimum $ 5,000,000               5,000,000     $ 5,000,000
Minimum sales revenue target in 2016                 22,500,000      
Minimum sales revenue target in 2015                 11,000,000      
Reduced minimum sales revenue target in 2015                 $ 10,000,000      
Debt instrument default interest rate percentage 18.00%               18.00%      
Cure right ratio                 2.50%